OBJECTIVE: Circulating microRNAs have been recognized as promising biomarkers for various diseases. The present study aimed to explore the potential roles of circulating miR-149, miR-424 and miR-765 as non-invasive biomarkers for the diagnosis of coronary artery disease in middle-aged (40–60-year-old) patients. METHODS: Sixty-five stable coronary artery disease patients (49–57 years old), 30 unstable coronary artery disease patients (49–58 years old), and 32 non-coronary artery disease patients (49–-57 years old) who were matched for age, sex, smoking habits, hypertension and diabetes were enrolled in this study. Total RNA was isolated from plasma with TRIzol reagent. Circulating miRNA levels were measured by quantitative real-time polymerase chain reaction. RESULTS: Circulating miR-149 levels were decreased 4.49-fold in stable coronary artery disease patients (1.18 ± 0.84) and 5.09-fold in unstable coronary artery disease patients (1.04 ± 0.65) compared with non-coronary artery disease patients (5.30 ± 2.57) (p<0.001). Circulating miR-424 levels were reduced 3.6-fold in stable coronary artery disease patients (1.18 ± 0.60) and 5-fold in unstable coronary artery disease patients (0.86 ± 0.54) compared with non-coronary artery disease patients (4.35 ± 2.20) (p<0.001). In contrast, circulating miR-765 levels were elevated 3.98-fold in stable coronary artery disease patients (6.09 ± 2.27) and 5.33-fold in unstable coronary artery disease patients (8.17 ± 2.77) compared with non-coronary artery disease patients (1.53 ± 0.99) (p<0.001). Receiver operating characteristic curve analysis revealed that the respective areas under the curve for circulating miR-149, miR-424 and miR-765 were 0.938, 0.919 and 0.968 in stable CAD patients and 0.951, 0.960 and 0.977 in unstable coronary artery disease patients compared with non-coronary artery disease patients. CONCLUSION: Our results suggest that circulating miR-149, miR-424 and miR-765 might be novel, non-invasive biomarkers for the diagnosis of coronary artery disease in middle-aged patients. However, future prospective trials in large patient cohorts are necessary before reaching a solid conclusion.

Sugarcane smut disease caused by the fungus Sporisorium scitamineum is one of the important fungal diseases affecting sugarcane yield and sucrose content around the world. Cultivar resistance is the most appropriate control method for this disease. In this study, 37 BC1 lines chosen from the crossing YC96-40 (F1 of Erianthus arundinaceus) × CP84-1198 (commercial sugarcane cultivar) and 42 BC2 lines chosen from the crossing YCE01-116 (BC1 of E. arundinaceus) × Neijiang57-416 (commercial sugarcane cultivar) were evaluated for smut resistance using artificial inoculation. The results showed that of 79 tested BC1 and BC2 lines of E. arundinaceus, 10 (12.7%) were highly to moderately resistant to smut. BC1 of E. arundinaceus had more resistant lines than BC2 of E. arundinaceus. Of the 37 tested BC1 lines of E. arundinaceus, seven (18.9%) were highly to moderately resistant, while three (7.1%) of the 42 tested BC2 lines of E. arundinaceus were highly to moderately resistant to smut. The resistant lines identified in this study could be used as sources of smut resistance in sugarcane breeding programs.